公开(公告)号：US20070146289A1

公开(公告)日：2007-06-28

申请号：US11535524

申请日：2006-09-27

Applicant: Hong-Woo Lee ,  Kye-Hun Lee ,  Jong-Hwan Lee

Inventor： Hong-Woo Lee ,  Kye-Hun Lee ,  Jong-Hwan Lee

IPC: G09G3/36

CPC classification number: G09G3/3677 ,  G09G2300/0439 ,  G09G2310/0281 ,  G09G2310/0286 ,  G11C19/184

Abstract: A shift register includes a plurality of stages connected to one another to sequentially generate output signals. Each of the stages has a plurality of output terminals, and each of the output terminals is connected to at least two gate lines and outputs a first output voltage alternately to the at least two gate lines to turn on thin film transistors.

Abstract translation: 移位寄存器包括彼此连接的多个级，以顺序地产生输出信号。 每个级具有多个输出端子，并且每个输出端子连接到至少两条栅极线并且交替地向至少两个栅极线输出第一输出电压以导通薄膜晶体管。

公开(公告)号：US07229980B2

公开(公告)日：2007-06-12

申请号：US11048310

申请日：2005-01-31

Applicant: Sang Joon Lee ,  Hee Jong Shin ,  Min Hyo Ki ,  Su Kyoung Lee ,  Bok Young Kim ,  Hong Woo Lee

Inventor： Sang Joon Lee ,  Hee Jong Shin ,  Min Hyo Ki ,  Su Kyoung Lee ,  Bok Young Kim ,  Hong Woo Lee

IPC: A61K31/56 ,  C07D215/04

CPC classification number: C07D405/12 ,  C07J43/00

Abstract: Disclosed herein is a paroxetine cholate or cholic acid derivative salt and a composition comprising paroxetine and cholic acid or a derivative thereof. Further disclosed is a pharmaceutical composition comprising the paroxetine salt or the composition. The pharmaceutical composition can be formulated into an oral preparation for swallowing without water as an orally disintegrating tablet for paroxetine.

Abstract translation: 本文公开了帕罗西汀胆酸盐或胆酸衍生物盐和包含帕罗西汀和胆酸或其衍生物的组合物。 还公开了包含帕罗西汀盐或组合物的药物组合物。 作为帕罗西汀的口腔崩解片剂，可以将药物组合物配制成无水的口服制剂。

公开(公告)号：US06521316B2

公开(公告)日：2003-02-18

申请号：US09742215

申请日：2000-12-22

Applicant: Hong-Woo Lee ,  Joon-Young Choi ,  Hyon-Jong Cho ,  Hak-Do Yoo

Inventor： Hong-Woo Lee ,  Joon-Young Choi ,  Hyon-Jong Cho ,  Hak-Do Yoo

IPC: C30B2906

CPC classification number: C30B29/06 ,  C30B15/203 ,  C30B15/206 ,  Y10T428/21

Abstract: The present invention relates to a single crystalline silicon ingot, a single crystalline wafer, and a producing method thereof in accordance with the Czochralski method which enables reduction of a large defect area while increasing a micro-vacancy defect area in an agglomerated vacancy point area, which is the area between a central axis and an oxidation-induced stacking fault ring, by providing uniform conditions of crystal ingot growth and cooling and by adjusting a pulling rate for growing an ingot to grow, thus the oxidation-induced stacking fault ring exists only at an edge of the ingot radius.

Abstract translation: 本发明涉及一种单晶硅锭，单晶晶片及其制造方法，该方法能够减少大的缺陷面积，同时增加聚集的空位点区域的微空缺缺陷面积， 这是通过提供晶锭生长和冷却的均匀条件以及通过调整生长锭生长的牵引速率来产生中心轴和氧化诱发的堆垛层错环之间的区域，因此氧化诱导堆垛层错环只存在 在晶锭半径的边缘。

公开(公告)号：US06436921B1

公开(公告)日：2002-08-20

申请号：US09508656

申请日：2000-05-18

Applicant: Sang Woo Park ,  Dong Kin Kim ,  Kye-Jung Shin ,  Yong Koo Kang ,  Yong Zu Kim ,  Yong Ho Chung ,  Hong Woo Lee ,  Jae Doo Huh ,  Sang Joo Lee ,  Il Hong Suh ,  Bong Suk Ko

Inventor： Sang Woo Park ,  Dong Kin Kim ,  Kye-Jung Shin ,  Yong Koo Kang ,  Yong Zu Kim ,  Yong Ho Chung ,  Hong Woo Lee ,  Jae Doo Huh ,  Sang Joo Lee ,  Il Hong Suh ,  Bong Suk Ko

IPC: C07D47720

CPC classification number: C07D477/20 ,  C07D207/16 ,  Y02P20/55

Abstract: The present invention relates to carbapenem derivatives of Formula I, wherein X is carbonyl or sulfonyl, and a preparation method thereof. The carbapenem derivatives of the invention have excellent antibacterial properties and are thus useful as antibiotics.

Abstract translation: 本发明涉及式I的碳青霉烯衍生物及其制备方法，其中X为羰基或磺酰基。 本发明的碳青霉烯衍生物具有优异的抗菌性能，因此可用作抗生素。

公开(公告)号：US6040337A

公开(公告)日：2000-03-21

申请号：US311777

申请日：1999-05-13

Applicant: Chung Hong, II ,  Jung Woo Kim ,  Sang Joon Lee ,  Soon Kil Ahn ,  Nam Song Choi ,  Ryung Kee Hong ,  Hyoung Sik Chun ,  Seung Kee Moon ,  Hong Woo Lee

Inventor： Chung Hong, II ,  Jung Woo Kim ,  Sang Joon Lee ,  Soon Kil Ahn ,  Nam Song Choi ,  Ryung Kee Hong ,  Hyoung Sik Chun ,  Seung Kee Moon ,  Hong Woo Lee

IPC: C12P17/06 ,  A61K31/336 ,  A61K36/06 ,  A61P9/00 ,  A61P35/00 ,  C07D303/08 ,  C07D303/14 ,  C07D303/16 ,  C07D303/32 ,  C07D303/34 ,  C07D303/36 ,  C12R1/68 ,  A61K31/335 ,  C07D301/32

CPC classification number: C07D303/16 ,  C07D303/14 ,  C07D303/32 ,  C07D303/36

Abstract: Compounds useful as angiogenesis inhibiting agents and processes for their preparation are disclosed. In one embodiment, the compounds of the invention are represented by Formula 1: ##STR1## Also disclosed is a pharmaceutical composition for inhibiting angiogenesis in a mammal, said composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.

Abstract translation: 公开了可用作血管生成抑制剂的化合物及其制备方法。 在一个实施方案中，本发明的化合物由式1表示：还公开了用于抑制哺乳动物血管生成的药物组合物，所述组合物包含式1化合物或其药学上可接受的盐作为活性成分。